Inhaler update

alert warning
A problem whereby some pharmacies may be unable to process claims for supply of an inhaler is now subject to an interim solution The 1 July 2023 PBS Schedule included approved changes to the listings of the form “budesonide 400 microgram/actuation + formoterol (eformoterol) fumarate dihydrate 12 microgram/actuation powder for inhalation” for the purpose of

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous IR reforms will cost jobs employers warn
Next Don’t give up on interns